Lansdowne Partners (Uk) LLP Cytokinetics Inc Transaction History

Lansdowne Partners (Uk) LLP

  • $672 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019
SELL
$7.95 - $11.25 $11.6 Million - $16.4 Million
-1,459,706 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$5.95 - $10.19 $7.07 Million - $12.1 Million
-1,188,275 Reduced 44.87%
1,459,706 $11.8 Million
Q3 2017

Nov 13, 2017
BUY
$12.0 - $15.0 $31.8 Million - $39.7 Million
2,647,981
2,647,981 $38.4 Million

Others Institutions Holding CYTK

# of Institutions
409
Shares Held
125M
Call Options Held
4.55M
Put Options Held
2.42M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $3.91B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Lansdowne Partners (Uk) LLP Portfolio

Follow Lansdowne Partners (Uk) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lansdowne Partners (Uk) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lansdowne Partners (Uk) LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email